Londinia Opportunities Analyses - 09/23/2022 (GMT) AMICUS THERAPEUTICS INC. - 1H

- USD (-)

- 15 min delayed data - NASDAQ Stocks

Type:	Stocks
Ticker:	FOLD
ISIN:

Londinia

Oops, I was wrong about that analysis. My threshold for invalidation has been broken.

U.S. Stocks
Timeframe : 1H
- Analysis generated on
Status : INVALID

Summary of the analysis

Trends

Short term: Strongly bearish

Underlying: Strongly bearish

Technical indicators

78%

17%

My opinion

Bearish under 10.08 USD

My targets

9.43 USD (-4.78%)

8.73 USD (-11.79%)

My analysis

The bearish trend is currently very strong for AMICUS THERAPEUTICS INC.. As long as the price remains below the resistance at 10.08 USD, you could try to take advantage of the bearish rally. The first bearish objective is located at 9.43 USD. The bearish momentum would be revived by a break in this support. Sellers would then use the next support located at 8.73 USD as an objective. Crossing it would then enable sellers to target 8.60 USD. Be careful, given the powerful bearish rally underway, excesses could lead to a short-term rebound. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.

In the very short term, the general bearish sentiment is confirmed by technical indicators. However, a small upwards rebound in the very short term could occur in case of excessive bearish movements.

Force

8.4

Analysis too old. There are no more charts available.

Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.

Additional analysis

Quotes

The AMICUS THERAPEUTICS INC. rating is 9.90 USD. The price is lower by -4.62% since the last closing and was traded between 9.90 USD and 10.36 USD over the period. The price is currently at 0% from its lowest and -4.44% from its highest.

9.90

10.36

9.90

Here is a more detailed summary of the historical variations registered by AMICUS THERAPEUTICS INC.:

The study of the highest / lowest by the Central Records scanner shows the following result:

New LOW record (1 month)

Type : Bearish

Timeframe : Weekly

Technical

A technical analysis in 1H of this AMICUS THERAPEUTICS INC. chart shows a sharp bearish trend. The signals given by moving averages are 92.86% bearish. This strong bearish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.

An assessment of technical indicators shows a strong bearish signal.
Caution: the Central Indicators scanner currently detects an excess:

CCI indicator is oversold : under -100

Type : Neutral

Timeframe : 1 hour

Williams %R indicator is oversold : under -80

Type : Neutral

Timeframe : 1 hour

Other results related to technical indicators were also found by the Central Indicators scanner:

Pivot points : price is under support 1

Type : Neutral

Timeframe : Weekly

Pivot points : price is under support 3

Type : Neutral

Timeframe : 1 hour

The analysis of the price chart with Central Patterns scanners does not return any result.

The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.

ProTrendLines

Price

	S3	S2	S1	Price	R1	R2	R3
ProTrendLines	6.60	7.90	8.60	9.90	10.08	10.42	10.88
Change (%)	-33.33%	-20.20%	-13.13%	-	+1.82%	+5.25%	+9.90%
Change	-3.30	-2.00	-1.30	-	+0.18	+0.52	+0.98
Level	Major	Intermediate	Major	-	Major	Minor	Intermediate

Attention could also be paid to pivot points to set price objectives:

Daily

Pivot points	S3	S2	S1	PP	R1	R2	R3
Standard	9.80	9.97	10.17	10.34	10.54	10.71	10.91
Camarilla	10.28	10.31	10.35	10.38	10.41	10.45	10.48
Woodie	9.83	9.98	10.20	10.35	10.57	10.72	10.94
Fibonacci	9.97	10.11	10.20	10.34	10.48	10.57	10.71

Weekly

Pivot points	S3	S2	S1	PP	R1	R2	R3
Standard	8.73	9.43	10.02	10.72	11.31	12.01	12.60
Camarilla	10.27	10.38	10.50	10.62	10.74	10.86	10.98
Woodie	8.69	9.40	9.98	10.69	11.27	11.98	12.56
Fibonacci	9.43	9.92	10.22	10.72	11.21	11.51	12.01

Monthly

Pivot points	S3	S2	S1	PP	R1	R2	R3
Standard	6.44	8.09	9.66	11.31	12.88	14.53	16.10
Camarilla	10.35	10.64	10.94	11.23	11.53	11.82	12.12
Woodie	6.40	8.07	9.62	11.29	12.84	14.51	16.06
Fibonacci	8.09	9.32	10.08	11.31	12.54	13.30	14.53

Numerical data

The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:

Technical indicators

Moving averages

RSI (14):	30.72
MACD (12,26,9):	-0.1700
Directional Movement:	-8.85
AROON (14):	-85.71
DEMA (21):	10.15
Parabolic SAR (0,02-0,02-0,2):	10.47
Elder Ray (13):	-0.33
Super Trend (3,10):	10.64
Zig ZAG (10):	9.93
VORTEX (21):	0.7700
Stochastique (14,3,5):	4.80
TEMA (21):	10.12
Williams %R (14):	-97.89
Chande Momentum Oscillator (20):	-0.87
Repulse (5,40,3):	-2.8000
ROCnROLL:	2
TRIX (15,9):	-0.1500
Courbe Coppock:	10.30

MA7:	10.53
MA20:	11.00
MA50:	11.22
MA100:	9.99
MAexp7:	10.19
MAexp20:	10.34
MAexp50:	10.55
MAexp100:	10.81
Price / MA7:	-5.98%
Price / MA20:	-10.00%
Price / MA50:	-11.76%
Price / MA100:	-0.90%
Price / MAexp7:	-2.85%
Price / MAexp20:	-4.26%
Price / MAexp50:	-6.16%
Price / MAexp100:	-8.42%

Quotes : - 15 min delayed data - Actions NASDAQ

News

The last news published on AMICUS THERAPEUTICS INC. at the time of the generation of this analysis was as follows: